BPA for brekiya
Active Awarded Last action
- Contract number
- 36E79726A0013
- Awardee
-
Amneal Pharmaceuticals Of New York, LLC UEI LVEBAQTPN615
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 51% complete
- IDV ceiling
- $7,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement, awarded to Amneal Pharmaceuticals of New York, LLC by the National Acquisition Center on April 21, 2026, establishes a single-award indefinite delivery vehicle with a ceiling value of $7.5 million and an ultimate completion date of April 20, 2027. The contract operates under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and requires no set-aside designation, reflecting open competition for these specialized pharmaceutical supplies. Based on Amneal's established contracting history and expertise, this BPA is designated for the procurement of Brekiya, supporting the government's pharmaceutical supply chain requirements through the National Acquisition Center's acquisition authority.
Amneal Pharmaceuticals brings substantial experience in fulfilling federal pharmaceutical requirements, with demonstrated success delivering specialized medications including sodium oxybate products to multiple federal agencies, particularly the Department of Veterans Affairs and the Department of Defense. The contractor's prior performance under related Federal Supply Schedule contracts and blanket purchase agreements positions the company to effectively manage the delivery order requirements under this agreement. The National Acquisition Center, which serves as the civilian federal agency funding this contract, will issue individual delivery orders against the BPA to meet specific pharmaceutical procurement needs, with performance and billing conducted in accordance with terms established in the parent GSA schedule and the individual task order specifications.
Quick answers
Who was awarded contract 36E79726A0013?
36E79726A0013 was awarded to Amneal Pharmaceuticals Of New York, LLC by National Acquisition Center (Headquarters) on April 21, 2026.
How much is contract 36E79726A0013 worth?
36E79726A0013's own ceiling is $7,500,000.
Who can order from contract 36E79726A0013?
36E79726A0013 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79726A0013 under another contract?
Yes. 36E79726A0013 is a blanket purchase agreement under 36F79722D0161, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79726A0013 competed?
The extent of competition for 36E79726A0013 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV